info:eu-repo/semantics/article
Differential tissue distribution of discrete typing units after drug combination therapy in experimental Trypanosoma cruzi mixed infection
Fecha
2021-11Registro en:
Strauss, Mariana; Lo Presti, Maria Silvina; Ramirez Gomez, Juan Carlos; Bazán, Paola Carolina; Velázquez López, Daniela Alejandra; et al.; Differential tissue distribution of discrete typing units after drug combination therapy in experimental Trypanosoma cruzi mixed infection; Cambridge University Press; Parasitology; 148; 13; 11-2021; 1595-1601
0031-1820
1469-8161
CONICET Digital
CONICET
Autor
Strauss, Mariana
Lo Presti, Maria Silvina
Ramirez Gomez, Juan Carlos
Bazán, Paola Carolina
Velázquez López, Daniela Alejandra
Báez, Alejandra Lidia
Paglini, Patricia Adriana
Schijman, Alejandro Gabriel
Rivarola, Hector Walter
Resumen
The aim of the present work was to evaluate the distribution of the different clones of the parasite prevailing after treatment with benznidazole (BZ) and clomipramine (CLO), in mice infected with Trypanosoma cruzi, Casibla isolate which consists of a mixture of two discrete typing units (DTUs). Albino Swiss mice were infected and treated with high and low concentrations of BZ (100 or 6.25 mg/kg), CLO (5 or 1.25 mg/kg), or the combination of both low doses (BZ6.25 + CLO1.25), during the acute phase of experimental infection. Treatment efficacy was evaluated by comparing parasitaemia, survival and tissular parasite presence. For DTUs genotyping, blood, skeletal and cardiac muscle samples were analysed by multiplex quantitative polymerase chain reaction. The combined treatment had similar outcomes to BZ6.25; BZ100 was the most effective treatment, but it failed to reach parasite clearance and produced greater histological alterations. Non-Treated mice and the ones treated with monotherapies showed both DTUs while BZ6.25 + CLO1.25 treated mice showed only TcVI parasites in all the tissues studied. These findings suggest that the treatment may modify the distribution of infecting DTUs in host tissues. Coinfection with T. cruzi clones belonging to different DTUs reveals a complex scenario for the treatment of Chagas disease and search for new therapies.